Cleared Traditional

K832801 - OREIA II B-HCG, ENZYME INNUNOASSAY

K832801 is an FDA 510(k) clearance for OREIA II B-HCG, manufactured by Organon, Inc.. The device is a Class 2 Chemistry device with product code JHI cleared through the Traditional 510(k) pathway after a 112-day FDA review.

K832801 · Organon, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1983
Decision
112d
Days
Class 2
Risk

K832801 is an FDA 510(k) clearance for the OREIA II B-HCG, ENZYME INNUNOASSAY. Classified as Visual, Pregnancy Hcg, Prescription Use (product code JHI), Class II - Special Controls.

Submitted by Organon, Inc. (Walker, US). The FDA issued a Cleared decision on December 8, 1983 after a review of 112 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1155 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Organon, Inc. devices

FDA 510(k) Submission Details - K832801

510(k) Number K832801 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 18, 1983
Decision Date December 08, 1983
Days to Decision 112 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
24d slower than avg
Panel avg: 88d · This submission: 112d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JHI Device Classification - Class 2, Special Controls

Product Code JHI Visual, Pregnancy Hcg, Prescription Use
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1155
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - JHI Visual, Pregnancy Hcg, Prescription Use

All 289
Devices cleared under the same product code (JHI) and FDA review panel - the closest regulatory comparables to K832801.
TANDEM VISUAL HCG IMMUNOENZYMETRIC
K834000 · Hybritech, Inc. · Feb 1984
STAR HCG MONOCLONAL ANTIBODY IMMUNORAD
K832796 · Syncor Intl. Corp. · Jan 1984
TANDEM R-TOTAL B-GCG KIT
K833194 · Hybritech, Inc. · Jan 1984
MODIFIED CHORIO-SHURE
K832892 · Nuclear Medical Laboratories, Inc. · Oct 1983
BHCG RIA KIT
K831264 · Micromedic Systems · Jun 1983
PBI BHCG RIA KIT
K831302 · Pacific Biotech, Inc. · Jun 1983